Life Sciences Archives - Page 5 of 17 - EverGlade

Life Sciences

BARDA Seeks Input on “Protection Before Day One” Influenza Vaccines with Pandemic Coverage

Leave a Comment / All Posts, BARDA, Life Sciences / By

Download the RFI Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR), has released a Request for Information (RFI) titled “Protection Before Day One Vaccine: Advancing Broadly Protective Seasonal Influenza Vaccines with Pandemic Coverage.” Through this market research effort, BARDA is seeking feedback from industry, academia, and

BARDA Seeks Input on “Protection Before Day One” Influenza Vaccines with Pandemic Coverage Read More »

DARPA Releases TA1/TA2 Solicitation for RAPIID Blood Analog Systems for Far-Forward Trauma Care

Leave a Comment / All Posts, DARPA, Defense, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released Program Solicitation DARPA-PS-26-124 for the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. RAPIID aims to develop a deployable blood analog system capable of providing the life-saving functions of stored whole blood without requiring cold-chain storage or donor logistics. This

DARPA Releases TA1/TA2 Solicitation for RAPIID Blood Analog Systems for Far-Forward Trauma Care Read More »

BARDA Seeks Input on Medical Countermeasures for Drug-Resistant Fungal Infections

Leave a Comment / All Posts, BARDA, Life Sciences / By

Download the Solicitation The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), has issued a Request for Information (RFI) to better understand the current development landscape for antifungal medical countermeasures. BARDA plays a central role in advancing

BARDA Seeks Input on Medical Countermeasures for Drug-Resistant Fungal Infections Read More »

BARDA Seeks Input on AI-Enabled Discovery of Broad-Spectrum Small-Molecule Filovirus Therapeutics

Leave a Comment / All Posts, BARDA, Life Sciences / By

Download the Solicitation The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has issued a Request for Information (RFI) focused on AI-Enabled Discovery of Broad-Spectrum Small-Molecule Inhibitors for Filoviruses. Filoviruses, including Ebola virus (EBOV), Sudan virus

BARDA Seeks Input on AI-Enabled Discovery of Broad-Spectrum Small-Molecule Filovirus Therapeutics Read More »

DARPA Explores Universal Biomolecule Purification Platforms Through New MTO RFI

Leave a Comment / All Posts, DARPA, Emerging Technologies, Life Sciences / By

Download the Solicitation The Defense Advanced Research Projects Agency (DARPA), through its Microsystems Technology Office (MTO), has released Request for Information (RFI) DARPA-SN-26-66 focused on biomolecule purification technologies. The RFI seeks information on novel purification methods capable of enabling a universal platform for separating and recovering multiple large and complex molecules from complex biological feedstocks

DARPA Explores Universal Biomolecule Purification Platforms Through New MTO RFI Read More »

ARPA-H’s THEA Program Seeks Breakthrough Optic Nerve Imaging Technologies

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Download the Solicitation The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Mission Office, has released a Sources Sought notice titled “Novel and Enhanced Modalities for Optic Nerve Imaging” (ARPA-H-SS-26-157). This request is being issued in support of ARPA-H’s Transplantation of Human Eye Allografts (THEA) program, an ambitious initiative focused on

ARPA-H’s THEA Program Seeks Breakthrough Optic Nerve Imaging Technologies Read More »

ARPA-H’s HEARING Program Aims to Revolutionize Brain-Driven Hearing Restoration

Leave a Comment / All Posts, ARPA-H, Emerging Technologies, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures (HSF) Office, has released an Innovative Solutions Opening (ISO) for Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING), ARPA-H-SOL-26-154. The program seeks to fundamentally rethink hearing loss treatment by shifting the focus from the ear alone to the brain’s auditory cortex. ARPA-H estimates

ARPA-H’s HEARING Program Aims to Revolutionize Brain-Driven Hearing Restoration Read More »

ARPA-H Launches IGoR Program to Transform Biomedical Research Infrastructure

ARPA-H Launches IGoR Program to Transform Biomedical Research Infrastructure

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

DOWNLOAD THE SOLICITATION The Advanced Research Projects Agency for Health (ARPA-H) has released the Intelligent Generator of Research (IGoR) Innovative Solutions Opening (ISO), a bold initiative designed to fundamentally transform how biomedical research is conducted. Managed through ARPA-H’s Proactive Health Office, the program seeks to address longstanding inefficiencies in scientific discovery by creating an artificial

ARPA-H Launches IGoR Program to Transform Biomedical Research Infrastructure Read More »

DARPA’s RAPIID Program shelf stable blood analogs

DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs

Leave a Comment / All Posts, DARPA, Emerging Technologies, Life Sciences / By

DARPA-SN-26-77 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued Special Notice DARPA-SN-26-77 to announce forthcoming areas of interest for the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. As part of DARPA’s broader mission to accelerate breakthrough technologies for national security, this initiative aims to address one of

DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs Read More »

ARPA-H TIGAR Biopreservation

ARPA-H TIGAR Opens a New Lane for Biopreservation Innovation

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

DOWNLOAD THE SOLICITATION ARPA-H’s new Technology InteGrator and AcceleratoR (TIGAR) Innovative Solutions Opening (ISO) is a tightly scoped opportunity for government contractors and their research partners to reshape how complex biologics, tissues, and organs are stored, transported, and deployed at scale. By seeding high-risk, high-impact biopreservation concepts, TIGAR aims to unlock temperature-flexible storage for increasingly

ARPA-H TIGAR Opens a New Lane for Biopreservation Innovation Read More »

MCDC RFI mNGS Solutions

MCDC Seeks Portable mNGS Solutions for Rapid Pathogen Detection

Leave a Comment / All Posts, CPE CBRND, Defense, Life Sciences / By

MCDC-RFI-Agnostic-Metagenomic-Next-Generation-Sequencing-for-Clinical-Diagnostics Overview of Solicitation The Medical CBRN Defense Consortium (MCDC), managed by Advanced Technology International (ATI) in support of the Capability Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND), has released a Request for Information (RFI) titled Agnostic Metagenomic Next-Generation Sequencing (mNGS) for Clinical Diagnostics. Unlike traditional targeted assays, which require

MCDC Seeks Portable mNGS Solutions for Rapid Pathogen Detection Read More »

MCDC RFI Host-Based Diagnostics

MCDC’s Host-Based Diagnostics for Acute Infections RFI

Leave a Comment / All Posts, CPE CBRND, Defense, Life Sciences / By

MCDC Request for Information HOST-BASED DIAGNOSTICS Final A Shift Toward Host-Response Diagnostics The Medical CBRN Defense Consortium (MCDC), managed by Advanced Technology International (ATI), has released a Request for Information (RFI) titled Host-Based Diagnostics for Acute Infections. Issued in support of the Capability Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND),

MCDC’s Host-Based Diagnostics for Acute Infections RFI Read More »

Scroll to Top